Literature DB >> 21207937

Incorporation of basic side chains into cryptolepine scaffold: structure-antimalarial activity relationships and mechanistic studies.

João Lavrado1, Ghislain G Cabal, Miguel Prudêncio, Maria M Mota, Jiri Gut, Philip J Rosenthal, Cecília Díaz, Rita C Guedes, Daniel J V A dos Santos, Elena Bichenkova, Kenneth T Douglas, Rui Moreira, Alexandra Paulo.   

Abstract

The synthesis of cryptolepine derivatives containing basic side-chains at the C-11 position and their evaluations for antiplasmodial and cytotoxicity properties are reported. Propyl, butyl, and cycloalkyl diamine side chains significantly increased activity against chloroquine-resistant Plasmodium falciparum strains while reducing cytotoxicity when compared with the parent compound. Localization studies inside parasite blood stages by fluorescence microscopy showed that these derivatives accumulate inside the nucleus, indicating that the incorporation of a basic side chain is not sufficient enough to promote selective accumulation in the acidic digestive vacuole of the parasite. Most of the compounds within this series showed the ability to bind to a double-stranded DNA duplex as well to monomeric hematin, suggesting that these are possible targets associated with the observed antimalarial activity. Overall, these novel cryptolepine analogues with substantially improved antiplasmodial activity and selectivity index provide a promising starting point for development of potent and highly selective agents against drug-resistant malaria parasites.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21207937     DOI: 10.1021/jm101383f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Design, Synthesis and Evaluation of Bifunctional Acridinine-Naphthalenediimide Redox-Active Conjugates as Antimalarials.

Authors:  Srikanta Dana; Sudhir Kumar Keshri; Jyoti Shukla; Kunwar Somesh Vikramdeo; Neelima Mondal; Pritam Mukhopadhyay; Suman Kumar Dhar
Journal:  ACS Omega       Date:  2016-09-01

2.  A naphthalimide derived fluorescent sensor for solid-phase screening of cucurbit[7]uril-guest interactions.

Authors:  Gyan Hari Aryal; Cooper Hawkins Battle; Tod A Grusenmeyer; Mengyuan Zhu; Janarthanan Jayawickramarajah
Journal:  Chem Commun (Camb)       Date:  2016-02-07       Impact factor: 6.222

3.  Recent Advances in the Chemistry and Pharmacology of Cryptolepine.

Authors:  Steven D Shnyder; Colin W Wright
Journal:  Prog Chem Org Nat Prod       Date:  2021

4.  Physicochemical Profiling and Comparison of Research Antiplasmodials and Advanced Stage Antimalarials with Oral Drugs.

Authors:  Amritansh Bhanot; Sandeep Sundriyal
Journal:  ACS Omega       Date:  2021-02-25

5.  Biological activities of nitidine, a potential anti-malarial lead compound.

Authors:  Jérome Bouquet; Marion Rivaud; Séverine Chevalley; Eric Deharo; Valérie Jullian; Alexis Valentin
Journal:  Malar J       Date:  2012-03-09       Impact factor: 2.979

6.  KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines.

Authors:  João Lavrado; Hugo Brito; Pedro M Borralho; Stephan A Ohnmacht; Nam-Soon Kim; Clara Leitão; Sílvia Pisco; Mekala Gunaratnam; Cecília M P Rodrigues; Rui Moreira; Stephen Neidle; Alexandra Paulo
Journal:  Sci Rep       Date:  2015-04-08       Impact factor: 4.379

7.  Proteomic analysis of Plasmodium falciparum response to isocryptolepine derivative.

Authors:  Kitiya Rujimongkon; Mathirut Mungthin; Jumreang Tummatorn; Sumate Ampawong; Poom Adisakwattana; Usa Boonyuen; Onrapak Reamtong
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

Review 8.  Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight.

Authors:  Champa Keeya Tudu; Anustup Bandyopadhyay; Manoj Kumar; Tuyelee Das; Samapika Nandy; Mimosa Ghorai; Abilash Valsala Gopalakrishnan; Jarosław Proćków; Abhijit Dey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-17       Impact factor: 3.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.